Clinical Effect of Low-Dose, Long-Term Roxithromycin Chemotherapy in Patients with Chronic Sinusitis

Nobuhiko Kimura, Keiko Nishioka, Kazunori Nishizaki, Teruhiro Ogawa, Yoshihiro Naitou, Yu Masuda

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

We studied the clinical efficacy of roxithromycin (RXM) administered at the daily dosage of one tablet (150mg) for 3 months in 30 patients with chronic sinusitis. The effectiveness of this drug was evaluated on a four-point scale. Subjective and objective symptoms disappeared or decreased markedly, especially postnasal drip and nature of discharge in 80 percent or more of the patients. All symptoms significantly decreased (P <0.001; headache P <0.05), except for the sensation of foul odor. Symptoms improved even in those cases in which Haemophilus influenzae was detected. It is suggested that RXM produces some clinically beneficial effect through an immunological and or anti-inflammatory mechanisms in addition to its antibiotic effect.

Original languageEnglish
Pages (from-to)33-37
Number of pages5
JournalActa Medica Okayama
Volume51
Issue number1
Publication statusPublished - Feb 1997

Fingerprint

Roxithromycin
Chemotherapy
Sinusitis
Drug Therapy
Haemophilus influenzae
Odors
Tablets
Headache
Anti-Inflammatory Agents
Anti-Bacterial Agents
Pharmaceutical Preparations
Odorants

Keywords

  • Chronic sinusitis
  • Clinical evaluation
  • Long-term
  • Low-dose administration
  • Roxithromycin

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Clinical Effect of Low-Dose, Long-Term Roxithromycin Chemotherapy in Patients with Chronic Sinusitis. / Kimura, Nobuhiko; Nishioka, Keiko; Nishizaki, Kazunori; Ogawa, Teruhiro; Naitou, Yoshihiro; Masuda, Yu.

In: Acta Medica Okayama, Vol. 51, No. 1, 02.1997, p. 33-37.

Research output: Contribution to journalArticle

Kimura, N, Nishioka, K, Nishizaki, K, Ogawa, T, Naitou, Y & Masuda, Y 1997, 'Clinical Effect of Low-Dose, Long-Term Roxithromycin Chemotherapy in Patients with Chronic Sinusitis', Acta Medica Okayama, vol. 51, no. 1, pp. 33-37.
Kimura, Nobuhiko ; Nishioka, Keiko ; Nishizaki, Kazunori ; Ogawa, Teruhiro ; Naitou, Yoshihiro ; Masuda, Yu. / Clinical Effect of Low-Dose, Long-Term Roxithromycin Chemotherapy in Patients with Chronic Sinusitis. In: Acta Medica Okayama. 1997 ; Vol. 51, No. 1. pp. 33-37.
@article{2466aefd7b8e49508e725d28a172ee62,
title = "Clinical Effect of Low-Dose, Long-Term Roxithromycin Chemotherapy in Patients with Chronic Sinusitis",
abstract = "We studied the clinical efficacy of roxithromycin (RXM) administered at the daily dosage of one tablet (150mg) for 3 months in 30 patients with chronic sinusitis. The effectiveness of this drug was evaluated on a four-point scale. Subjective and objective symptoms disappeared or decreased markedly, especially postnasal drip and nature of discharge in 80 percent or more of the patients. All symptoms significantly decreased (P <0.001; headache P <0.05), except for the sensation of foul odor. Symptoms improved even in those cases in which Haemophilus influenzae was detected. It is suggested that RXM produces some clinically beneficial effect through an immunological and or anti-inflammatory mechanisms in addition to its antibiotic effect.",
keywords = "Chronic sinusitis, Clinical evaluation, Long-term, Low-dose administration, Roxithromycin",
author = "Nobuhiko Kimura and Keiko Nishioka and Kazunori Nishizaki and Teruhiro Ogawa and Yoshihiro Naitou and Yu Masuda",
year = "1997",
month = "2",
language = "English",
volume = "51",
pages = "33--37",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "1",

}

TY - JOUR

T1 - Clinical Effect of Low-Dose, Long-Term Roxithromycin Chemotherapy in Patients with Chronic Sinusitis

AU - Kimura, Nobuhiko

AU - Nishioka, Keiko

AU - Nishizaki, Kazunori

AU - Ogawa, Teruhiro

AU - Naitou, Yoshihiro

AU - Masuda, Yu

PY - 1997/2

Y1 - 1997/2

N2 - We studied the clinical efficacy of roxithromycin (RXM) administered at the daily dosage of one tablet (150mg) for 3 months in 30 patients with chronic sinusitis. The effectiveness of this drug was evaluated on a four-point scale. Subjective and objective symptoms disappeared or decreased markedly, especially postnasal drip and nature of discharge in 80 percent or more of the patients. All symptoms significantly decreased (P <0.001; headache P <0.05), except for the sensation of foul odor. Symptoms improved even in those cases in which Haemophilus influenzae was detected. It is suggested that RXM produces some clinically beneficial effect through an immunological and or anti-inflammatory mechanisms in addition to its antibiotic effect.

AB - We studied the clinical efficacy of roxithromycin (RXM) administered at the daily dosage of one tablet (150mg) for 3 months in 30 patients with chronic sinusitis. The effectiveness of this drug was evaluated on a four-point scale. Subjective and objective symptoms disappeared or decreased markedly, especially postnasal drip and nature of discharge in 80 percent or more of the patients. All symptoms significantly decreased (P <0.001; headache P <0.05), except for the sensation of foul odor. Symptoms improved even in those cases in which Haemophilus influenzae was detected. It is suggested that RXM produces some clinically beneficial effect through an immunological and or anti-inflammatory mechanisms in addition to its antibiotic effect.

KW - Chronic sinusitis

KW - Clinical evaluation

KW - Long-term

KW - Low-dose administration

KW - Roxithromycin

UR - http://www.scopus.com/inward/record.url?scp=0031066350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031066350&partnerID=8YFLogxK

M3 - Article

C2 - 9057933

AN - SCOPUS:0031066350

VL - 51

SP - 33

EP - 37

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 1

ER -